Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The transplantation of spinal cord progenitor cells (SCPCs) derived from human-induced pluripotent stem cells (iPSCs) has beneficial effects in treating spinal cord injury (SCI). However, the presence of residual undifferentiated iPSCs among their differentiated progeny poses a high risk as these cells can develop teratomas or other types of tumors post-transplantation. Despite the need to remove these residual undifferentiated iPSCs, no specific surface markers can identify them for subsequent removal. By profiling the size of SCPCs after a 10-day differentiation process, we found that the large-sized group contains significantly more cells expressing pluripotent markers. In this study, we used a sized-based, label-free separation using an inertial microfluidic-based device to remove tumor-risk cells. The device can reduce the number of undifferentiated cells from an SCPC population with high throughput (ie, >3 million cells/minute) without affecting cell viability and functions. The sorted cells were verified with immunofluorescence staining, flow cytometry analysis, and colony culture assay. We demonstrated the capabilities of our technology to reduce the percentage of OCT4-positive cells. Our technology has great potential for the "downstream processing" of cell manufacturing workflow, ensuring better quality and safety of transplanted cells.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016845 | PMC |
| http://dx.doi.org/10.1093/stcltm/szae002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Proteomics and single cell profiling identify keratin driven preexisting immunity influences lung squamous carcinoma neoadjuvant therapy.
Cancer Lett
August 2025
Department of Respiratory and Critical Care Medicine, Center for Oncology Medicine, The Fourth Affiliated Hospital of School of Medicine, International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China; Zhejiang Key Laboratory of Precision Diagnosis and Treat
Lung squamous cell carcinoma (LUSC) demonstrates heterogeneous responses to neoadjuvant immune checkpoint blockade, necessitating biomarkers for outcome prediction. Here, we identify tumor keratinization as a key determinant of therapeutic resistance. In 470 LUSC patients, elevated serum CYFRA 21-1 correlated with non-complete pathological response (non-CPR), while CK5/6 immunohistochemistry revealed strong association between keratinization and residual tumor burden.
View Article and Find Full Text PDFAberrant Positivity for BCL6 Corepressor (BCOR) Immunohistochemistry in Undifferentiated Round Cell Sarcoma of the Kidney With Melanoma of the Ureter.
Cureus
July 2025
Digestive and General Surgery, Shimane University Faculty of Medicine, Izumo, JPN.
BCL6 corepressor (BCOR)-rearrangement sarcoma, an undifferentiated round cell sarcoma, is rare, and its pathophysiology is diverse. A 14-year-old girl presented with a tumor in the left kidney with invasion of the left iliopsoas muscle, left renal vein, and inferior vena cava. An immunohistochemical analysis of the tumor biopsy specimen was positive for BCOR, but no BCOR gene aberrations were detected.
View Article and Find Full Text PDFIn silico chemical fingerprint screening identifies fisetin as a novel stemotoxic flavonoid.
Biomed Pharmacother
September 2025
College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Research Institute of Pharmaceutical Science, Seoul National University, Seoul 08826, Republic of Korea. Electronic address:
Despite recent advances in stem cell therapy using human pluripotent stem cells (hPSCs), the risk of teratoma formation due to residual undifferentiated cells remains a significant safety concern. Numerous small molecules, termed stemotoxic agents, have been developed to eliminate these residual cells, such as the promising natural flavonoid quercetin (QC). Application of QC in clinical settings during the differentiation of dopaminergic neurons from hPSCs has demonstrated its safety and efficacy in selectively targeting residual hPSCs without affecting neural stem cells (NSCs).
View Article and Find Full Text PDFElimination of tumorigenic pluripotent stem cells from their differentiated cell therapy products: An important step toward ensuring safe cell therapy.
Stem Cell Reports
July 2025
Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. Electronic address:
Human pluripotent stem cells (hPSCs) are considered a promising tool for regenerative medicine due to their unique self-renewal and multi-lineage differentiation capabilities. Although over 100 clinical trials have employed hPSC-derived products to treat life-threatening diseases, the tumorigenic risk posed by residual undifferentiated hPSCs remains a formidable obstacle to their clinical implementation. In this review, we summarize current strategies to eliminate tumorigenic hPSCs, most of which target hPSC-specific markers, and critically evaluate the advantages and limitations of each approach.
View Article and Find Full Text PDFApplication of Real-Time Indocyanine Green Fluorescence Imaging in Recurrent Nasopharyngeal Carcinoma Surgery.
Ann Surg Oncol
June 2025
Department of Otolaryngology Head and Neck Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Background: Indocyanine green (ICG) fluorescence imaging enhances cancer surgery precision, showing great potential for resection of tumors such as liver cancer. Although early-stage recurrent nasopharyngeal carcinoma (rNPC) can be surgically removed, residual tumors hinder effectiveness. The application of ICG fluorescence imaging in precision surgery for rNPC has been rarely reported.
View Article and Find Full Text PDF